Discover 1,024 paid clinical trials in Saint Paul, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,024
DESIFOR-EXPAND (MHIF)
for
Statin Therapy, Statin Adverse Reaction, Statin
Location: Minneapolis MN
Sponsor: Minneapolis Heart Institute Foundation
Sex: All
Age: 21+
Code: NCT06804980
Recruiting
Coronary Computed Tomography Angiography (CCTA) for the Pre-procedural Planning of Percutaneous Coronary Intervention
for
Coronary Artery Disease, CT
Location: Minneapolis MN
Sponsor: Minneapolis Heart Institute Foundation
Sex: All
Age: 22+
Code: NCT07691502
Recruiting
OPN Balloon for SAFE Recanalization of Calcified Coronary Lesions
for
Coronary Arterial Disease (CAD), In Stent Restenosis,
Location: Minneapolis MN
Sponsor: Minneapolis Heart Institute Foundation
Sex: All
Age: 18+
Code: NCT07646444
Recruiting
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
for
Non-small Cell Lung Cancer (NSCLC)
Location: Minneapolis MN, Maple Grove MN, Peoria IL, Evanston IL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07361497
Phase 3, Recruiting
STRess Assessment of INterventional Cardiology Fellows and Attendings
for
Stress
Location: Minneapolis MN
Sponsor: Minneapolis Heart Institute Foundation
Sex: All
Age: 18+
Code: NCT07804927
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Alleviant ALLAY-HFrEF Study
for
Heart Failure
Location: Minneapolis MN, Naperville IL, St Louis MO,
Sponsor: Alleviant Medical, Inc.
Sex: All
Age: 18+
Code: NCT06812533
Recruiting
A Clinical Trial Assessing the Safety and Effectiveness of the DurAVR® THV System
for
Severe Aortic Stenosis, Valve-in-valve Procedures
Location: Minneapolis MN, St Louis MO, Wichita KS, Cincinnati OH,
Sponsor: Anteris Technologies Ltd.
Sex: All
Age: 18+
Code: NCT07194265
Recruiting
Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance
for
Heart Failure and Reduced Ejection Fraction,
Location: Minneapolis MN
Sponsor: Minneapolis Heart Institute Foundation
Sex: All
Age: 18+
Code: NCT07131631
Recruiting
Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
for
Aortic Regurgitation, Aortic Valve Insufficiency,
Location: Minneapolis MN, Rochester MN, Evanston IL, Chicago IL,
Sponsor: JenaValve Technology, Inc.
Sex: All
Age: 0+
Code: NCT06608823
Recruiting
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
for
Obstructive Hypertrophic Cardiomyopathy
Location: Minneapolis MN, Milwaukee WI, Omaha NE, Chicago IL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT05489705
Recruiting
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
for
Heart Attack, Enlarged Heart
Location: Minneapolis MN
Sponsor: Minneapolis Heart Institute Foundation
Sex: All
Age: 18 - 70+
Code: NCT05305911
Phase 2, Recruiting
ATLAS (AltaValve) Pivotal Trial
for
Mitral Regurgitation, Mitral Insufficiency,
Location: Minneapolis MN, Rochester MN, Kansas City MO,
Sponsor: 4C Medical Technologies, Inc.
Sex: All
Age: 18+
Code: NCT06465745
Recruiting
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)